Abound Wealth Management’s Guardian Pharmacy Services GRDN Stock Holding History

Abound Wealth Management’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$61.2K	Buy	+1,500	New	+$61.2K	0.01%	245

Other funds holding GRDN

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $620M AUM 38.17% 1-Year Est. Return

Park Avenue Securities New York $16.4B AUM 18.52% 1-Year Est. Return

Kings Path Partners Sugar Land, Texas $380M AUM 12.42% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Investment Research & Advisory Group Atlanta, Georgia $337M AUM 19.8% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Abound Wealth Management's GRDN Position: Q3 2026 in Review

Abound Wealth Management opened a new position in Guardian Pharmacy Services (GRDN) in Q3 2026: 1,500 shares worth $61.2K. The stake represents 0.01% of the portfolio and ranks #245 among its holdings.

19 funds tracked by Wall St. Rank hold GRDN as of Q3 2026.

Abound Wealth Management held 1,500 shares of Guardian Pharmacy Services worth $61.2K as of Q3 2026.
Guardian Pharmacy Services was a new Abound Wealth Management position in Q3 2026.
Guardian Pharmacy Services made up 0.01% of Abound Wealth Management's portfolio in Q3 2026, its #245 holding.
19 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q3 2026.

Based on Abound Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.